Holen Sie sich die Stockscreener-App
0.9326
0.23%
0.0021
Handel nachbörslich:
.93
-0.0026
-0.28%
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Shorts Report: Can Standard BioTools Inc grow without dilution2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat
Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn
Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn
LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LAB Technical Analysis & ETF Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan
Director at Standard BioTools (LAB) takes RSUs instead of cash pay - Stock Titan
Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - MarketBeat
Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm
Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax bill - Stock Titan
Standard BioTools (LAB) SVP disposes shares for tax withholding - Stock Titan
Tax withholding trims Standard BioTools (LAB) CFO share stake - Stock Titan
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Standard Biotools earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Standard BioTools Details SomaLogic Sale and Profitability Path - TipRanks
LAB Forecasts Revenue Between $80 Million and $85 Million for FY - GuruFocus
Standard BioTools: Q4 Earnings Snapshot - marketscreener.com
Standard BioTools (NASDAQ:LAB) Announces Earnings Results - MarketBeat
Standard BioTools Q4 Earnings Report: What Investors Need to Know - Benzinga
Preview: Standard BioTools's Earnings - Benzinga
LABSTANDARD BIOTOOLS INC Latest Stock News & Market Updates - Stock Titan
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc. (LAB) Stock Analysis: Healthcare Innovator Shows 34.78% Potential Upside - DirectorsTalk Interviews
What hedge fund activity signals for Standard BioTools Inc. stock2025 Geopolitical Influence & Short-Term High Return Ideas - mfd.ru
MSN Money - MSN
Standard BioTools (LAB) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
How Standard BioTools Inc. stock performs during Fed tightening cyclesWeekly Trend Recap & Short-Term Trading Alerts - mfd.ru
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic - MSN
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Standard BioTools Inc. (LAB) Stock Analysis: Unpacking a 39.64% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
LAB PE Ratio & Valuation, Is LAB Overvalued - Intellectia AI
Can Standard BioTools Inc. (FLB) stock survive global slowdownFed Meeting & Weekly Setup with ROI Potential - mfd.ru
Standard BioTools Inc.'s (NASDAQ:LAB) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Can Standard BioTools Inc. stock outperform in a bear marketSwing Trade & Community Trade Idea Sharing Platform - mfd.ru
Will Standard BioTools Inc. stock recover after earningsJuly 2025 Retail & Reliable Trade Execution Plans - mfd.ru
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewswire
Swing Trade: Will BayFirst Financial Corp benefit from geopolitical trends2025 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Market Outlook: Can Standard BioTools Inc stock outperform in a bear market2025 Top Gainers & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Standard BioTools Strengthens Balance Sheet with Major Divestiture - AD HOC NEWS
Standard BioTools Inc. (LAB) Stock Analysis: Exploring the 25% Potential Upside Amid Market Challenges - DirectorsTalk Interviews
Aug Patterns: Is Standard BioTools Inc impacted by rising ratesJuly 2025 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
Market Pulse: Will Standard BioTools Inc stock recover after earnings2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
Illumina completes acquisition of SomaLogic - marketscreener.com
Will Standard BioTools Inc. stock reach Wall Street targets2025 Performance Recap & High Return Trade Opportunity Guides - mfd.ru
Weekly Earnings: How volatile is Standard BioTools Inc stockJuly 2025 Chart Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Standard BioTools completes sale of SomaLogic to Illumina for $350 million - Investing.com Nigeria
Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with a 9.93% Potential Upside - DirectorsTalk Interviews
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):